6α-Methylprogesterone
| 6α-Methylprogesterone | |
|---|---|
| 6α-Methylprogesterone.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 1247-64-9 |
| PubChem | 200550 |
| DrugBank | |
| ChemSpider | 173656 |
| KEGG | |
6α-Methylprogesterone is a synthetic progestin, a type of progestogen which is a class of hormones that includes the natural hormone progesterone. It is a derivative of progesterone with a methyl group at the 6α position.
Chemical Structure[edit]
6α-Methylprogesterone has a chemical structure similar to that of progesterone, with the addition of a methyl group at the 6α position. This modification can affect the pharmacokinetics and pharmacodynamics of the compound, potentially altering its biological activity and metabolism.
Pharmacology[edit]
As a progestin, 6α-Methylprogesterone mimics the effects of progesterone in the body. It binds to progesterone receptors and can influence various physiological processes, including the menstrual cycle, pregnancy, and embryogenesis. Progestins are often used in hormonal contraception and hormone replacement therapy.
Uses[edit]
6α-Methylprogesterone may be used in various medical applications, particularly in the management of menstrual disorders, endometriosis, and as part of hormone replacement therapy for menopause. It may also be used in contraceptive formulations.
Side Effects[edit]
The side effects of 6α-Methylprogesterone are similar to those of other progestins and can include nausea, headache, breast tenderness, and mood changes. Long-term use may be associated with an increased risk of certain health conditions, such as thrombosis and breast cancer.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
